Abstract:Intracranial atherosclerotic stenosis (ICAS) is one of the most common causes of stroke worldwide, in particular in Chinese, Black and Hispanic populations compared with Caucasians [ 1 Wong L.K. Global burden of intracranial atherosclerosis. Int. J. Stroke. 2006; 1: 158-159 Crossref PubMed Scopus (445) Google Scholar , 2 Gorelick P.B. Wong K.S. Bae H.J. Pandey D.K. Large artery intracranial occlusive disease: a large worldwide burden but a relatively neglected frontier. Stroke. 2008; 39: 2396-2399 Crossref PubMed Scopus (518) Google Scholar ]. In addition to the medical therapy, angioplasty and stenting are alterative surgical approaches. However, recent AHA/ASA guideline on stroke prevention recommended not to adopt stenting with the Wingspan stent system as an initial treatment for patients with stroke or transient ischemic attack attributable to severe (70%–99%) ICAS (class III, level C) [ [3] Kernan W.N. Ovbiagele B. Black H.R. Bravata D.M. Chimowitz M.I. Ezekowitz M.D. et al. Guidelines for the prevention of stroke in patients with stroke and transient ischemic attack: a guideline for healthcare professionals from the American Heart Association/American Stroke Association. Stroke. 2014; 45: 2160-2236 Crossref PubMed Scopus (3181) Google Scholar ]. This recommendation was formulated based on the only randomized clinical trial — Stenting and Aggressive Medical Management for Prevention Recurrent Stroke and Intracranial Stenosis (SAMMPRIS) trial, which demonstrated that stenting had higher risk for 30-day and long-term stroke and death than aggressive medical therapy in patients with severe ICAS [ 4 Chimowitz M.I. Lynn M.J. Derdeyn C.P. Turan T.N. Fiorella D. Lane B.F. et al. Stenting versus aggressive medical therapy for intracranial arterial stenosis. N. Engl. J. Med. 2011; 365: 993-1003 Crossref PubMed Scopus (1397) Google Scholar , 5 Derdeyn C.P. Chimowitz M.I. Lynn M.J. Fiorella D. Turan T.N. Janis L.S. et al. Aggressive medical treatment with or without stenting in high-risk patients with intracranial artery stenosis (SAMMPRIS): the final results of a randomised trial. Lancet. 2014; 383: 333-341 Abstract Full Text Full Text PDF PubMed Scopus (576) Google Scholar ]. However, this trial was performed in Caucasians [ [4] Chimowitz M.I. Lynn M.J. Derdeyn C.P. Turan T.N. Fiorella D. Lane B.F. et al. Stenting versus aggressive medical therapy for intracranial arterial stenosis. N. Engl. J. Med. 2011; 365: 993-1003 Crossref PubMed Scopus (1397) Google Scholar ]. Asians have more ICAS, and more diffuse lesions, whether the SAMMPRIS result validate in Chinese patients, also needs further investigation.

Intracranial atherosclerotic stenosis: risk factors, diagnosis, and treatment

Prevalence and Outcomes of Symptomatic Intracranial Large Artery Stenoses and Occlusions in China: the Chinese Intracranial Atherosclerosis (CICAS) Study.

Endovascular Treatment for Acute Large Vessel Occlusion Due to Underlying Intracranial Atherosclerotic Disease

Intracranial atherosclerotic disease

Medical Treatment of Intracranial Atherosclerosis: An Update

Endovascular Treatment of Intracranial Atherosclerotic Stenosis: Current Debates and Future Prospects

The Safety and Long-Term Outcomes of Angioplasty and Stenting in Symptomatic Intracranial Atherosclerotic Stenosis

Optimal Medical Management of Atherosclerotic Intracranial Stenosis

Epidemiology, Pathophysiology, and Imaging of Atherosclerotic Intracranial Disease

Emergent Large Vessel Occlusion due to Intracranial Stenosis: Identification, Management, Challenges, and Future Directions

High-Risk Intracranial Atherosclerotic Stenosis Despite Aggressive Medical Treatment: Protocol for a Prospective Nested Case-Control Study

Cerebral Blood Flow Evaluation of Intensive Rosuvastatin Therapy in Stroke/Transient Ischemic Attack Patients with Intracranial Arterial Atherosclerotic Stenosis Study: Rationale and Design

Cerebral haemodynamics in symptomatic intracranial atherosclerotic disease: a narrative review of the assessment methods and clinical implications

Long-term recurrence of ischemic events in patients with intracranial atherosclerotic stenosis stratified by symptoms and pathogenesis

Intracranial Atherosclerotic Stenosis Is Associated with Cognitive Impairment in Patients with Nondisabling Ischemic Stroke: A pCASL-Based Study

Risk of Recurrence of Symptomatic Intracranial Atherosclerosis in Posterior Circulation Seen to Be Higher Than That in Anterior Circulation in Long-Term Follow-Up

Intracranial Atherosclerosis: from Anatomy to Pathophysiology

Abstract Number ‐ 247: Multimodal imaging approach for the diagnosis of (ICAD): basic principles, current and future perspectives

Hemodynamics and stroke risk in intracranial atherosclerotic disease

Stroke incidence and cognitive outcomes of intracranial atherosclerotic stenosis: study protocol for a multicenter, prospective, observational cohort study

Intracranial Atherosclerosis Burden and Stroke Recurrence for Symptomatic Intracranial Artery Stenosis (sICAS)